Filing Details
- Accession Number:
- 0001683168-22-000105
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-01-05 19:56:42
- Reporting Period:
- 2022-01-03
- Accepted Time:
- 2022-01-05 19:56:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 704562 | Avid Bioservices Inc. | CDMO | Pharmaceutical Preparations (2834) | 953698422 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1552642 | R Mark Ziebell | 2642 Michelle Drive, Suite 200 Tustin CA 92780 | V. P., General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 Par Value | Acquisiton | 2022-01-03 | 6,429 | $3.29 | 13,858 | No | 4 | M | Direct | |
| Common Stock, $0.001 Par Value | Disposition | 2022-01-03 | 6,429 | $27.53 | 7,429 | No | 4 | S | Direct | |
| Common Stock, $0.001 Par Value | Acquisiton | 2022-01-03 | 14,246 | $17.01 | 21,675 | No | 4 | M | Direct | |
| Common Stock, $0.001 Par Value | Disposition | 2022-01-03 | 14,246 | $27.70 | 7,429 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2022-01-03 | 6,429 | $0.00 | 6,429 | $3.29 |
| Common Stock | Stock Option (right to buy) | Disposition | 2022-01-03 | 14,246 | $0.00 | 14,246 | $17.01 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 279,859 | 2022-06-20 | No | 4 | M | Direct | |
| 265,613 | 2022-12-27 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 14, 2021.
- Represents a weighted average sales price per share. These shares were sold at prices ranging from $27.04 to $28.67. The Reporting Person has provided to the Issuer, and hereby undertakes to provide the SEC staff or a security holder of the Issuer, upon request, information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- Represents a weighted average sales price per share. These shares were sold at prices ranging from $27.50 to $28.97. The Reporting Person has provided to the Issuer, and hereby undertakes to provide the SEC staff or a security holder of the Issuer, upon request, information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- Stock option granted to the reporting person on June 20, 2012 vested quarterly over a three (3) year period and was fully vested as of June 20, 2015.
- Stock option granted to the reporting person on December 27, 2012 vested quarterly over a two (2) year period and was fully vested as of December 27, 2014.
Billionaire Hedge Funds
